Filing Details
- Accession Number:
- 0001209191-15-086152
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-12-18 17:22:19
- Reporting Period:
- 2015-12-16
- Filing Date:
- 2015-12-18
- Accepted Time:
- 2015-12-18 17:22:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1197023 | S Joshua Boger | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-12-16 | 10,400 | $35.64 | 275,684 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-12-16 | 2,000 | $114.72 | 273,684 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-12-16 | 2,600 | $115.72 | 271,084 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-12-16 | 4,400 | $116.47 | 266,684 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-12-16 | 400 | $117.73 | 266,284 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-12-16 | 1,000 | $118.81 | 265,284 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2015-12-16 | 10,400 | $0.00 | 10,400 | $35.64 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 63,200 | 2016-02-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 13,286 | Indirect | 401(k) |
| Common Stock | 122,700 | Indirect | Common Stock held in trust |
Footnotes
- Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
- Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $114.72 (range $114.20 to $115.19).
- Open market sales reported on this line occurred at a weighted average price of $115.72 (range $115.20 to $116.04).
- Open market sales reported on this line occurred at a weighted average price of $116.47 (range $116.21 to $117.15).
- Open market sales reported on this line occurred at a weighted average price of $117.73 (range $117.42 to $117.92).
- Open market sales reported on this line occurred at a weighted average price of $118.81 (range $118.52 to $119.21).
- Fully vested.
Billionaire Hedge Funds
